
INOVIO Eyes Accelerated Approval for Groundbreaking DNA Medicine INO-3107
PLYMOUTH MEETING, PA — Biotechnology firm INOVIO (NASDAQ: INO) recently announced plans to submit a Biologics License Application (BLA) for its innovative DNA medicine, INO-3107, potentially paving the way for …
INOVIO Eyes Accelerated Approval for Groundbreaking DNA Medicine INO-3107 Read More